Status:
COMPLETED
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
Lead Sponsor:
Medical University of South Carolina
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this research is to treat vitiligo with a topical PGF2α, microneedling and excimer laser. The goal is to have greater repigmentation than the standard of care (excimer) after 12 weeks o...
Eligibility Criteria
Inclusion
- All patients 18 years and older with the diagnosis of Vitiligo.
Exclusion
- Female patients currently pregnant or lactating
- Female patients with plans to come pregnant during the next 3 months
- Allergic reactions to topical or oral prostaglandins
- Uncontrolled skin disease
- History of glaucoma
- Concomitant disease or therapy that interferes with the diagnosis that might interfere with vitiligo diagnosis sand evaluation.
- Patients currently using other treatments for Vitiligo, such as topical steroids, calcineurin inhibitors, and Vitamin D analogs within 2 weeks of study initiation
- Inability or unwillingness of subject or legal guardian/representative to give
Key Trial Info
Start Date :
November 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04738149
Start Date
November 2 2021
End Date
May 15 2022
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29407